Cargando…
Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers
The global COVID-19 pandemic resulted in widespread harms but also rapid advances in vaccine development, diagnostic testing, and treatment. As the disease moves to endemic status, the need to identify characteristic biomarkers of the disease for diagnostics or therapeutics has lessened, but lessons...
Autores principales: | Onoja, Anthony, von Gerichten, Johanna, Lewis, Holly-May, Bailey, Melanie J., Skene, Debra J., Geifman, Nophar, Spick, Matt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531504/ https://www.ncbi.nlm.nih.gov/pubmed/37762673 http://dx.doi.org/10.3390/ijms241814371 |
Ejemplares similares
-
Multi-Omics Reveals Mechanisms of Partial Modulation of COVID-19 Dysregulation by Glucocorticoid Treatment
por: Spick, Matt, et al.
Publicado: (2022) -
Single-Cell
Lipidomics Using Analytical Flow LC-MS
Characterizes the Response to Chemotherapy in Cultured Pancreatic
Cancer Cells
por: Saunders, Kyle D. G., et al.
Publicado: (2023) -
Metabolomics Markers of COVID-19 Are Dependent on Collection Wave
por: Lewis, Holly-May, et al.
Publicado: (2022) -
An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics
por: Spick, Matt, et al.
Publicado: (2022) -
Untargeted saliva metabolomics by liquid chromatography—Mass spectrometry reveals markers of COVID-19 severity
por: Frampas, Cecile F., et al.
Publicado: (2022)